fda announcement semaglutide Novo's Wegovy becomes first GLP-1 drug approved for MASH Hims & Hers stock falls

The 2026 Frontiers review lists, across this compound class: prolactin and cortisol elevations, appetite change, dysglycaemia, fluid retention, myalgia and arthralgia, injection-site reactions [1]

For now, the study adds to a growing body of evidence suggesting that GLP-1 medications may influence health outcomes far beyond weight management

Bourgonje et al., 2021

Our product selection spans 9 distinct forms of dosage such as capsules, tablets, gummies, syrups, powders, and drops ensuring we offer a solution for every consumer's preference and requirement, across various market segments

You can even schedule in-person appointments if offered by the provider you choose